Preclinical study of safety and immunogenicity of combined rubella and human papillomavirus vaccines: Towards enhancing vaccination uptake rates in developing countries
about
Preclinical study of safety and immunogenicity of combined rubella and human papillomavirus vaccines: Towards enhancing vaccination uptake rates in developing countries
description
scientific article published on 08 June 2019
@en
name
Preclinical study of safety an ...... rates in developing countries
@en
type
label
Preclinical study of safety an ...... rates in developing countries
@en
prefLabel
Preclinical study of safety an ...... rates in developing countries
@en
P2093
P1476
Preclinical study of safety an ...... rates in developing countries
@en
P2093
Asmaa Gohar
Magdy A Amin
Nahla Shehata
P304
P356
10.1016/J.PVR.2019.100172
P577
2019-06-08T00:00:00Z